1. Liao, Xinyi, Zhang, Shuxia, Li, Xincheng, Song, Libing, Li, Jun. 2024. Dynamic structural remodeling of LINC01956 enhances temozolomide resistance in MGMT-methylated glioblastoma. In Science translational medicine, 16, eado1573. doi:10.1126/scitranslmed.ado1573. https://pubmed.ncbi.nlm.nih.gov/39356744/
2. Zheng, Qingliang, Hou, Jin, Zhou, Ye, Li, Zhenyang, Cao, Xuetao. 2017. The RNA helicase DDX46 inhibits innate immunity by entrapping m6A-demethylated antiviral transcripts in the nucleus. In Nature immunology, 18, 1094-1103. doi:10.1038/ni.3830. https://pubmed.ncbi.nlm.nih.gov/28846086/
3. Yang, Guang, Wang, Yun, Wang, Kairui, Liu, Xinjia, Yang, Jing. 2024. Oncogenic DDX46 promotes pancreatic cancer development and gemcitabine resistance by facilitating the JMJD6/CDK4 signaling pathway. In Neoplasma, 71, 231-242. doi:10.4149/neo_2024_230904N469. https://pubmed.ncbi.nlm.nih.gov/38764294/
4. Lin, Quan, Jin, Hong-Juan, Zhang, Duo, Gao, Ling. 2020. DDX46 silencing inhibits cell proliferation by activating apoptosis and autophagy in cutaneous squamous cell carcinoma. In Molecular medicine reports, 22, 4236-4242. doi:10.3892/mmr.2020.11509. https://pubmed.ncbi.nlm.nih.gov/33000271/